Stock analysis · Bull Rankings model

CTVA analysis

Corteva, Inc.Agricultural Inputs. Scored on the same transparent model behind the daily rankings.

Agriculture & Food
CTVA
Corteva, Inc. · Agricultural Inputs
FCF$629mC+
Rev+3.7%C+
D/E0.19B+
P/E49.6xC
PEG1.31B
42.8Score
$82.81$55.3B
1Y Target$92.10Analyst consensus · 20 analysts
5Y Target$134.84Compound horizon
10Y Target$200.03Long-dated conviction
FCF$629mTTM
C+
FCF $629m — respectable but not differentiating
Rev+3.7%TTM YoY
C+
Revenue +3.7% — steady but below market-beating range
D/E0.19
B+
D/E 0.19 — below the Basic Materials debt median (≈40th pctile)
P/E49.6x
C
P/E 49.6 — expensive vs Basic Materials peers (≈90th pctile)
PEG1.31
B
PEG 1.31 — acceptable premium for growth

Forward price target — the 1-year figure is the analyst consensus where the stock is covered; the 5- and 10-year figures compound our earnings estimate from there. The DCF below is a separate cross-check on intrinsic value (what it's worth today), not another target.

Quality-growth score · 42.8
Quality59.3
Growth41.7
Value31.7
Why this score
  • Raising its dividend
  • Short track record
Entry · Margin of safety
52-week rangeNear 52-week high
9% off the 12-month high
vs DCF fair value241% aboveest. fair value ~$24
What the price assumes: free cash flow compounding at ~37% a year for the next decade — vs the ~9% a year our model projects from current growth and analyst estimates.
Quality signals · context only
Gross profitability21% · Bgross profit ÷ total assets (Novy-Marx)

Model-generatedGenerated by the Bull Rankings model from this company's reported fundamentals, and checked against the figures shown above.

Why now
Agricultural Inputs · market cap $55.3b. 9% off the 52-week high of $90.97. 20 sell-side analysts rate this a Buy with a mean 1-yr target of $92.10 (implying +11% upside).
Moat
$55.3b market cap gives the company enough scale to absorb fixed costs that subscale competitors can't, without yet being so large that growth has to come from acquisition.
Risk
Trailing P/E 50x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates. ROE 4% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
Horizon
1-3 yr $92.10 (20-analyst consensus) — fundamentals + valuation re-rating. 5 yr $134.84 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $200.03 if current growth sustains into durable earnings power.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.

CTVA vs the Top Picks average

PillarCTVABook avgDiff
Quality0.590.84-0.24
Growth0.420.87-0.45
Value0.320.76-0.44

Averaged across the 30 names in today's Top Picks (mean score 81.5). A name can beat these averages and still be absent from the book — it also applies concentration limits.

Trend
-8.7 over 47 daily scores
From 51.5 (Jun 22) → 42.8 (now)

One point per daily model run. The range autoscales, so a flat-looking line can still hide 1–2 point moves — read the From → To values for the actual range.

Analyst estimate revisions

30-day change-0.4%
90-day change+0.4%
Forward EPS estimate$4.12

Over the last 90 days, what analysts expect CTVA to earn is essentially unchanged. The estimate is derived from price and forward P/E captured at the same instant, so a moving share price does not move this number — only a changed forecast does.

A rising estimate means expectations are improving, not that the price has failed to keep up — and estimates get cut as readily as they get raised. It is not part of the Bull Rankings score. Biggest movers across the market →

Shares to buy
24
Position size
$1,987
4.0% of portfolio
Stop price
$62.11
25% below $82.81
$ at risk if stopped
$496.86
budget $500.00 · 1% of portfolio

Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.

Corteva, Inc. (CTVA): score, valuation & FAQ

Corteva, Inc. (CTVA) is a Agricultural Inputs company that scores 42.8 out of 100 on the Bull Rankings quality-growth model — a below-average reading. The score blends three pillars — quality (durable returns, healthy margins, low leverage), growth (revenue and earnings), and value (valuation versus sector peers) — into one number, refreshed daily; it is a screen, not a buy recommendation.

Its strongest graded signals are D/E (B+). On valuation, CTVA sits about 241% above our discounted-cash-flow fair value — the current price implies roughly 37% annual free-cash-flow growth over the next decade.

Is CTVA a good stock to buy?

Bull Rankings scores CTVA 42.8 out of 100 on its quality-growth model, which is a below-average reading. That is driven by D/E (B+). A score is a quantitative screen of Corteva, Inc.'s fundamentals, not personalised financial advice — weigh it against your own time horizon and risk tolerance, and read the risk factors below before acting.

Why does CTVA score 42.8 on Bull Rankings?

The quality-growth score blends three pillars — quality (returns on capital, margins, leverage, earnings quality), growth (revenue and earnings expansion), and value (valuation versus sector peers). CTVA earns its highest marks on D/E (B+). Each pillar is graded against sector-aware thresholds, then combined into the single 0–100 score.

Is CTVA overvalued or undervalued?

Based on $82.81, CTVA sits about 241% above our discounted-cash-flow fair value — the current price implies roughly 37% annual free-cash-flow growth over the next decade. It trades at a 49.6x P/E (graded C). Discounted-cash-flow estimates are sensitive to growth and discount-rate assumptions, so treat this as a cross-check, not a price target.

What are the main risks of investing in CTVA?

Trailing P/E 50x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates. ROE 4% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.

New to these metrics? The guides explain free cash flow, how the score works, and more in the learn hub — or run another name through the screener.

Bull Rankings is an automated fundamentals screen for research and education. It is not investment advice, and nothing here is a recommendation to buy or sell any security. Do your own research and consider consulting a licensed financial advisor.

More Chemicals stocks by score

All Basic Materials rankings →

Analyze another ticker →